Functional imaging and genetics in schizophrenia: search for endophenotypes

精神分裂症的功能成像和遗传学：寻找内表型

• 批准号: 7669321
• 负责人: GABOR FICHTINGER
• 金额: $ 12.95万
• 依托单位: BRIGHAM AND WOMEN'S HOSPITAL
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-08-01 至 2010-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7669321
• 关键词: Address; Adverse effects; Alleles; Amygdaloid structure; Anatomy; Anterior; Antipsychotic Agents; Area; Auditory Hallucination; Automobile Driving; Biological; Brain; Brain imaging; Brain-Derived Neurotrophic Factor; COMT gene; Catechol O-Methyltransferase; Characteristics; Clinical; Collaborations; Computer software; Data; Data Analyses; Disease; Dorsal; Dose; Emotional; Equilibrium; Functional Imaging; Functional Magnetic Resonance Imaging; Functional disorder; Funding; Genes; Genetic; Genetic Markers; Genetic Variation; Grant; Haplotypes; Hippocampus (Brain); Image; Inferior; Intervention; Link; Measurable; Measures; Medial; Methods; Neurocognitive; Neurocognitive Deficit; Numbers; Output; Parietal; Parietal Lobe; Patients; Pattern; Pharmaceutical Preparations; Prefrontal Cortex; Principal Investigator; Prosencephalon; Relative (related person); Risk; Role; Schizophrenia; Shapes; Short-Term Memory; Signal Transduction; Stream; Structure; Structure of superior frontal gyrus; Superior temporal gyrus; Symptoms; Syndrome; System; Tardive Dyskinesia; Techniques; Testing; Variant; angular gyrus; atypical antipsychotic; emotional stimulus; endophenotype; frontal lobe; genetic analysis; improved; interest; myelination; neural circuit; neurocognitive test; neuroimaging; neuropathology; oligodendrocyte-myelin glycoprotein; programs; putamen; receptor density; response; serotonin transporter; suicidal; suicidal patient

Schizophrenia is a heterogeneous group of disorders, which shares some commonality in symptoms and neuropathology. These different syndromes within schizophrenia are characterized by the predominance of distinct symptom profiles. The overarching theme of this proposal is to distinguish biological subtypes from among the clinical syndrome profiles, using the combined approach of functional brain imaging, genetic markers, and neurocognitive testing. Clinically defined syndromes respond differently to antipsychotic treatments; conventional antipsychotics can mitigate positive symptoms, for example, without particularly aiding in treating negative symptoms, while atypical antipsychotics have a small but measurable effect on negative symptoms. Neuroimaging and genetic analyses have begun to elucidate the relationships among the clinical profiles and treatment response. We have found that there are genetic markers that can differentiate certain drug responders from nonresponders. Genetic markers as well can predict the occurrence of side effects to certain pharmacological interventions. These treatment response subtypes could represent more homogeneous forms of schizophrenia that may, in turn, have distinct brain structure/function characteristics. The aim of this proposal is to investigate the hypothesis that these syndrome profiles are a consequence of dysfunction in separate brain areas or circuits, all of which communicate with the dorsal prefrontal cortex (DPFC). The DPFC includes the dorsolateral prefrontal cortex (DLPFC; BA 46/ventral 9) and anterior superior frontal gyrus (dorsal BA 9). We hypothesize that the DPFC dysfunction commonly found in schizophrenia can arise from abnormalities in the DPFC output, itself, or from various circuits and combinations of circuits that ultimately interact with the DPFC. Our use of fMRI will focus on both local and extended circuitry that we hypothesize is involved in producing different aspects of schizophrenia. In the Background section (below) we discuss the specific brain areas that are implicated in schizophrenia and our hypotheses as to how these areas are functionally linked in producing dysfunction. To test these hypotheses, improved and more accurate methods of identification and segmentation of these brain areas are required. We propose to extend our circuitry analyses by adding clinical measures, neurocognitive assessments, and genetic data to determine common patterns that could serve as endophenotypes. The impetus for this combination is the fact that schizophrenia is heritable and associated with specific neurocognitive deficits. Combining such data is a developing field and brings with it many computational and statistical challenges due to the large numbers of variables relative to the number of subjects. As a Driving Biological Project (DPB), this endeavor requires computational strengths and strategies implementation software in an interactive collaboration among the projects funded by this grant to address the challenges of the emerging field of combined imaging and genetic data analysis.

精神分裂症是一种异质性疾病，在症状和神经病理上有一些共同点。精神分裂症中的这些不同综合征的特点是不同的症状概况占主导地位。本提案的首要主题是利用脑功能成像、遗传标记和神经认知测试的结合方法，从临床综合征概况中区分生物学亚型。